Vaccines in travel health: From risk assessment to priorities

Journal of Travel Medicine

Volumn 12, Issue 1, 2005, Pages 26-35

  Steffen, Robert ^a,d   Connor, Bradley A ^b,c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c New York Otology   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHOLERA VACCINE; DIPHTHERIA TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; TYPHOID VACCINE; VACCINE; YELLOW FEVER VACCINE;

BIOLOGICAL WARFARE; CHOLERA; DIPHTHERIA; EPIDEMIC ENCEPHALITIS; HEALTH CARE PLANNING; HEPATITIS A; HEPATITIS B; HUMAN; INFECTION; INFLUENZA; MEASLES; MENINGOCOCCOSIS; MORBIDITY; POLIOMYELITIS; PRACTICE GUIDELINE; RABIES; REVIEW; RISK ASSESSMENT; TETANUS; TRAVEL; TUBERCULOSIS; TYPHOID FEVER; VACCINATION; YELLOW FEVER;

EID: 13444301074     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2005.00006     Document Type: Review

References (64)

1. Centers for Disease Control and Prevention. Health information for international travel 2003-2004. Atlanta, GA: US Department of Health and Human Services, Public Health Service, 2003.
2. World Health Organization. International travel and health 2003. Geneva, Switzerland: World Health Organization, 2003.
3. Steffen R, Tornieporth N, Costa Clemens S, et al. Epidemiology of travelers' diarrhea: details on a global survey. J Travel Med 2004; 11:231-238.
4. Steffen R. Despite good tools, we do not effectively reduce travelers' hepatitis A. J Travel Med 2002; 9:1-2.
5. World Health Organization. International health regulations (1969). 3rd Ed. Geneva, Switzerland: World Health Organization, 1983.
6. World Health Organization. Yellow fever. (Fact sheet no. 100; revised December 2001) Available at: http//www.who.int/inf-fs/en/fact100.html (accessed Nov 5, 2002).
7. Centers for Disease Control and Prevention. Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:324-325.
8. Timaticweb.com. Available at: http://www.timaticweb.com (accessed Jan. 3, 2005).
9. Titball RW, Williamson ED, Dennis DT. Plague. In: Plotkin SA, Orenstein WA, eds. Vaccines. 44th Ed. Philadelphia: W.B. Saunders Company, 2004:999-1010.
10. Galazka A. The changing epidemiology of diphtheria in the vaccine era. J Infect Dis 2000; 181(Suppl 1):S2-S9.
11. Anonymous. Diphtheria in visitors to Africa. Commun Dis Rep CDR Wkly 1998; 8:289.
12. World Health Organization. Imported wild poliovirus causing poliomyelitis, Bulgaria, 2001. Wkly Epidemiol Rec 2001; 76:332-335.
13. Heymann DL, Aylward RB. Eradicating polio. N Engl J Med 2004; 35:1275-1277.
14. Löscher T, Keystone JS, Steffen R. Vaccination of travelers against hepatitis A and B. J Travel Med 1999; 6:107-114.
15. Correia JD, Shafer RT, Patel V, et al. Blood and body fluid exposure as a health risk for international travelers. J Travel Med 2001; 8:263-266.
16. Zuckerman JN, Steffen R. Risks of hepatitis B in travelers as compared to immunization status. J Travel Med 2000; 7:170-174.
17. Hutin YJF, Hauri AM, Armstrong GL. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ 2003; 327:1075.
18. Simonsen L, Kane A, Lloyd J, et al. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999; 77:789-800.
19. Rota JS, Rota PA, Redd SB, et al. Genetic analysis of measles viruses isolated in the United States, 1995-1996. J Infect Dis 1998; 177:204-208.
20. Uyeki TM, Zane SB, Bodnar UR, et al. Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory. Clin Infect Dis 2003; 36:1095-1102.
21. Centers for Disease Control and Prevention. Influenza B virus outbreak on a cruise ship: Northern Europe, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:137-140.
22. Miller JM, Tam TW, Maloney S, et al. Cruise ships: high-risk passengers and the global spread of new influenza viruses. Clin Infect Dis 2000; 31:433-438.
23. Leder K, Sundararajan V, Weld L, et al, for the GeoSentinel Surveillance Group. Respiratory tract infections in travelers: a review of the GeoSentinel Surveillance Network. Clin Infect Dis 2003; 36:399-406.
24. Mutsch M, Tavernini N, Marx A, et al. Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis 2005. [In press]
25. Wilder-Smith A, Goh KT, Paton NI. Experience of severe acute respiratory syndrome in Singapore: importation of cases, and defense strategies at the airport. J Travel Med 2003; 10:259-262.
26. Steffen R, Kane MA, Shapiro CN, et al. Epidemiology and prevention of hepatitis A in travelers. JAMA 1994; 272:885-889.
27. Teitelbaum P. An estimate of the incidence of hepatitis A in unimmunized Canadian travelers to developing countries. J Travel Med 2004; 11:102-106.
28. De Serres G, Duval B, Shadmani R, et al. Ineffectiveness of the current strategy to prevent hepatitis A in travelers. J Travel Med 2002; 9:10-16.
29. Forbes A, Williams R. Increasing age: an important adverse prognostic factor in hepatitis A virus infection. J R Coll Physicians Lond 1988; 22:237-239.
30. Fiore AE. Hepatitis A transmitted by food. Clin Infect Dis 2004; 38:705-715.
31. Gutersohn T, Steifen R, Van Damme P, et al. Hepatitis A infection in aircrews: risk of infection and cost-benefit analysis of hepatitis A vaccination. Aviat Space Environ Med 1996; 67:153-156.
32. Caumes E, Ehya N, Nguyen J, Bricaire F. Typhoid and paratyphoid fever: a 10-year retrospective study of 41 cases in a Parisian hospital. J Travel Med 2001; 8:293-297.
33. Mermin JH, Townes JM, Gerber M, et al. Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998; 158:633-638.
34. Steffen R. Typhoid vaccine, for whom? Lancet 1982; 1:615-616.
35. World Health Organization. Rabies, Asia. Wkly Epidemiol Rec 2001; 76:320-323.
36. Bernard KW, Fishbein DB. Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost? Vaccine 1991; 9:833-836.
37. Hatz CF, Bidaux JM, Eichenberger K, et al. Circumstances and management of 72 animal bites among long-term residents in the tropics. Vaccine 1995; 13:811-815.
38. World Health Organization. Review of reported rabies cases in Europe to the WHO Collaborating Centre Tübingen from 1977-2000. Rabies Bulletin Europe 2000; 24(4).
39. Fooks AR, Johnson N, Brookes SM, et al. Risk factors associated with travel to rabies endemic countries. J Appl Microbiol 2003; 94(Suppl):31-36.
40. Haupt W. Rabies: risk of exposure and current trends in prevention of human cases. Vaccine 1999; 17:1742-1749.
41. Wilde H, Briggs DJ, Meslin FX, et al. Rabies update for travel medicine advisors. Clin Infect Dis 2003; 37(1):96-100.
42. Koch S, Steffen R. Meningococcal disease in travelers: vaccination recommendations. J Travel Med 1994; 1:4-7.
43. Centers for Disease Control and Prevention. Exposure to travelers with meningococcal disease on aircrafts: United States, 1999-2001. MMWR Morb Mortal Wkly Rep 2001; 50:485-489.
44. Centers for Disease Control and Prevention. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1993; 42(RR-1):1-15.
45. Wittesjö B, Eitrem R, Niklasson B, et al. Japanese encephalitis after a 10-day holiday in Bali. Lancet 1995; 345:856-857.
46. Shlim DR, Solomon T. Japanese encephalitis vaccine for travelers: exploring the limits of risk. Clin Infect Dis 2002; 35:183-188.
47. Cobelens FGJ, van Deutekom H, Draayer-Jansen IWE, et al. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet 2000; 356:461-465.
48. Rieder HL. Risk of travel-associated tuberculosis. Clin Infect Dis 2001; 33:1393-1396.
49. Wittlinger F, Steifen R, Watanabe H, Handszuh H. Risk of cholera among western and Japanese travelers. J Travel Med 1995; 2:154-158.
50. Kessels BL, van Dijl R, van Keulen PH, Verburg GP. Tickencephalitis after a vacation in Southern Germany. Ned Tijdschr Geneeskd 1999; 143:1784-1786.
51. Slack R. Travel health: who should provide and who should pay. Health Hyg 2003; 24:6-7.
52. Van Damme PA, Van Herck K, Banatvala JE. Do we need hepatitis A booster vaccinations? J Travel Med 2004; 11:179-181.
53. Steffen R, DuPont HL, Wilder-Smith A. Manual of travel medicine and health. 2nd Ed. London: BC Decker, 2003.
54. Smith KC, Starke JR. Bacille Calmette-Guérin vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. Philadelphia: WB. Saunders Company, 2004:179-210.
55. Levine MM. Typhoid fever vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. Philadelphia: WB. Saunders Company, 2004:Chap 39.
56. Sack DA, Lang DR. Cholera vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. Philadelphia: WB. Saunders Company, 2004:905-918.
57. Wolters B, Junge U, Dziuba S, Roggendorf M. Immunogenicity of combined hepatitis A and B vaccine in elderly persons. Vaccine 2003; 21:3623-3628.
58. Barwick R. History of thymome and yellow fever vaccination. Lancet 2004; 364:936.
59. Berg SW, Mitchell BS, Hanson RK, et al. Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine. Clin Infect Dis 1997; 24:265-266.
60. Van Herck K, Castelli F, ZuckermanJ, et al. Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey. J Travel Med 2004; 11:3-8.
61. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1996; 45 (RR-15):1-30.
62. Robertson BH, D'Hondt EH, Speibring J, et al. Effect of post-exposure vaccination in a chimpanzee model of hepatitis A virus infection. J Med Virol 1994; 43:249-251.
63. Elliott JH, Kunze M, Torresi J. Hepatitis A vaccine failure. Lancet 2002; 359:1948-1949.
64. Junge U, Melching J, Dziuba S. Acute hepatitis A despite regular vaccination against hepatitis A and B. Deutsche Med Wschr 2002; 127:1581-1583.